SpreadLove In Organizations - Healthcare Leadership

Naji Gehchan

The Healthcare Leadership Podcast. Because we believe we can change the world by leading from a place of love. One story at a time. Hear global leaders' personal stories and inspiring journeys spreading love in their organizations bringing genuine care for people to thrive resulting in a positive impact for the company’s stakeholders and healthcare globally. https://spreadloveio.com/ https://www.linkedin.com/company/spreadloveio/ https://linktr.ee/spreadloveio

  1. hace 7 h

    Purpose Through Precision – Kristina Masson

    In this episode of Spread Love in Organizations, Kristina Masson, Co-Founder and Executive Vice President of Business Operations at Acrivon Therapeutics, shares her journey from scientist to entrepreneur and biotech executive. She reflects on how a passion for cancer research, combined with the right timing, technology, and partnerships, led to the creation of Acrivon and its pioneering precision proteomics platform. Kristina also discusses the challenges of building a company from the ground up, taking it public, and translating cutting-edge science into therapies that have the potential to transform patients' lives. The conversation explores the future of precision medicine and how Acrivon's AP3 platform is helping reshape oncology drug development by identifying predictive biomarkers, understanding resistance mechanisms, and enabling smarter clinical trial design. Kristina explains how integrating diagnostics, drug discovery, and therapeutics within one organization accelerates innovation while increasing the likelihood of delivering the right treatment to the right patient. She also shares insights into leading teams across the United States and Sweden and building a collaborative culture that fuels scientific excellence. Beyond science and business, the discussion turns to leadership. Kristina reflects on the importance of accountability, authenticity, kindness, and integrity in building high-performing organizations. She explains why love and high performance are not mutually exclusive and why leaders have a responsibility to remain focused on the ultimate goal: improving patients' lives. This episode offers an inspiring perspective on purpose-driven leadership, entrepreneurship, and creating lasting impact in healthcare. "When we have good science, good people, and good options for patients, it's our obligation to make it work." MEET OUR GUEST Kristina Masson, Co-Founder and Executive Vice President of Business Operations at Acrivon Therapeutics. Kristina Masson, Ph.D., MBA is a global biotech executive, entrepreneur, and scientist with extensive experience in company building, translational drug development, and operational leadership. She is Co-Founder and Executive Vice President of Business Operations at Acrivon Therapeutics (NASDAQ: ACRV), where she leads key business operations and works closely with the CEO and executive team to scale the organization and support corporate execution. Since co-founding Acrivon, she has helped grow the company from an early-stage startup into a public biotechnology company with more than 80 employees, building high-performing teams and an integrated U.S.–Scandinavian organizational culture. In parallel, Dr. Masson serves as President and CEO of Acrivon AB, the company’s wholly owned Swedish research subsidiary, where she oversees European operations and scientific infrastructure. Dividing her time between Boston and Lund, she plays an important role in aligning strategy, talent, and operations across the company’s U.S. and European teams. Prior to her current roles, Dr. Masson founded OncoSignature AB, a biotechnology company focused on biomarker discovery, which was later acquired by Acrivon Therapeutics and became foundational to the company’s proprietary technology platform. Earlier in her career, she was a Principal Scientist at Merrimack Pharmaceuticals and completed her postdoctoral fellowship at the Broad Institute of MIT and Harvard, where she conducted research at the intersection of molecular biology and systems science. Dr. Masson holds a Ph.D. in Molecular Signaling and an M.Sc. in Biomedicine from Lund University, as well as an Executive MBA from the MIT Sloan School of Management. She also serves as a mentor with the Termeer Institute. Click here for more episodes in partnership with The Termeer Institute.

    Purpose Through Precision – Kristina Masson
  2. 23 jul

    Science With Purpose – Amy Simon

    In this episode of Spread Love in Organizations, Naji is joined by Amy Simon, Chief Medical Officer of Beam, for a conversation about leadership, scientific innovation, humility, and the human side of healthcare. Amy shares her remarkable journey from physician-scientist and academic researcher at Tufts University to biotech executive leading the development of transformative medicines. She reflects on what drew her to medicine, her passion for solving complex problems, and how curiosity and a desire to bring scientific discoveries closer to patients shaped her career. Amy opens up about one of the most important transitions in her career: moving from academia, where she had built expertise and recognition, into biotech, where she had to relearn how to lead in a different environment. She shares the humility that came with realizing that technical expertise alone is not enough — effective leadership requires influence without authority, continuous learning, curiosity, and the ability to create environments where people feel safe to speak up. We discuss psychological safety, trust, healthy conflict, feedback, and the importance of building cultures where diverse perspectives can help teams make better decisions. We also explore the future of medicine and the promise of precision therapies, including how new technologies could transform the way we prevent and treat disease. Amy shares her hope for the next generation of leaders: people who are mission-driven, willing to challenge conventional thinking, and courageous enough to innovate beyond what has been done before. A powerful conversation on leadership as a never-ending journey, the responsibility we have to patients, and why bringing humanity, care, and even love into organizations can help us achieve extraordinary things together. "We never stop growing or needing to grow." MEET OUR GUEST Amy Simon, M.D. is Chief Medical Officer of Beam. Amy Simon, M.D. is Chief Medical Officer of Beam. Dr. Simon brings more than 20 years of clinical experience to Beam, serving in roles as a physician-scientist in academia and the biotechnology industry. Dr. Simon joins Beam from Alnylam Pharmaceuticals, where she spent over a decade in various roles with increasing responsibility for the clinical development of RNAi-based medicines, most recently serving as Vice President, Clinical Development. During her tenure at Alnylam, she led the successful execution of clinical programs from natural history studies to Phase 1 through Phase 4 studies, regulatory interactions with both U.S. and ex-U.S. authorities, and drug approvals in the U.S. and EU. Dr. Simon was the lead clinician developing GIVLAARI® (givosiran) for patients with acute hepatic porphyria, which was approved by the Food and Drug Administration in 2019. Prior to entering the biotech industry, Dr. Simon worked in academia at Tufts University, serving as a professor and a director of the Asthma Center in the Pulmonary and Critical Care Division at Tufts University School of Medicine and as a professor at Tufts Graduate School of Biomedical Science where her laboratory conducted basic science research on asthma. She began her career in clinical practice, training as a resident in internal medicine and as a fellow in pulmonary and critical care medicine at Tufts Medical Center. Dr. Simon holds a B.A. in History and Science from Harvard University, and an M.D. from Tufts University School of Medicine.

    Science With Purpose – Amy Simon
  3. 18 jun

    Reimagining Clinical Trials – Pedro Coelho

    In this episode of Spread Love in Organizations, Naji Gehchan sits down with Pedro Coelho, Founder and CEO of Biorce, to explore how artificial intelligence is transforming the future of clinical research. Pedro shares the deeply personal story that inspired his mission: the loss of his father to melanoma despite gaining access to an innovative clinical trial. That experience led him to question the inefficiencies of the clinical research ecosystem and ultimately fueled his determination to build technology that could help bring life-saving therapies to patients faster. Pedro discusses how Biorce is reimagining clinical development through an AI-powered operating system designed to support every stage of the process—from asset strategy and protocol design to site selection, patient matching, and study execution. He explains how AI can identify avoidable protocol amendments, optimize trial design, and help organizations make smarter decisions with greater speed and precision. The conversation offers a fascinating look at how AI is evolving from a productivity tool into a strategic partner for drug development teams. Beyond technology, Pedro reflects on leadership, culture, and the importance of keeping patients at the center of innovation. He shares why great leadership requires adaptability, humility, and a willingness to challenge conventional thinking. Together, Naji and Pedro explore a future where AI accelerates medical breakthroughs while human judgment, purpose, and compassion remain essential. It is an inspiring discussion about innovation, resilience, and the opportunity to transform healthcare for millions of patients around the world. "If you don't have a great culture, you will not succeed in the age of AI." MEET OUR GUEST Pedro Coelho Founder & CEO of Biorce. Pedro Coelho is Founder & CEO of Biorce, an AI-native company transforming how clinical trials are designed, optimized, and executed. After years advising pharma and biotech companies as a strategy consultant in the life sciences sector, Pedro saw firsthand how inefficiencies in the clinical research process were slowing access to life-saving treatments. The consequences weren’t just operational; they were human. Drugs were too expensive. Timelines too long. And too many patients were left behind. In 2024, he founded Biorce to change that. Biorce, short for “Biology’s Force,” is building the world’s first true AI assistant for clinical trials. Pedro is passionate about the intersection of technology, data, and human impact, and believes AI has a central role to play in reshaping how treatments reach those who need them most.

    Reimagining Clinical Trials – Pedro Coelho
  4. 11 jun

    Human Data Revolution – Greg Tietjen

    In this episode of Spread Love in Organizations, Naji Gehchan sits down with Greg Tietjen, Co-Founder and CEO of Revalia Bio, for a fascinating conversation that bridges science, technology, leadership, and humanity. Greg shares his unconventional journey—from studying English literature and pursuing a career in jazz guitar to becoming a physicist, scientist, Yale professor, and biotech entrepreneur. Along the way, he reflects on the life experiences, setbacks, and moments of reinvention that shaped his approach to learning, leadership, and purpose. At the heart of the discussion is Revalia Bio’s mission to transform the way medicines are developed by creating human-centered data platforms built around donated organs and advanced perfusion technologies. Greg explains how the industry’s biggest challenge is not a lack of innovation, but the gap between promising discoveries and successful patient outcomes. He shares his vision for “Human Data Trials,” a new approach designed to generate more predictive human data earlier in development, helping researchers make better decisions, reduce risk, and ultimately bring more effective therapies to patients. Beyond the science, Greg offers a thoughtful perspective on leadership, culture, and trust. He discusses the importance of stewardship, vulnerability, collaboration, and creating environments where people from different backgrounds can work together toward a shared mission. Drawing on lessons from music, academia, and entrepreneurship, he explores why the future of innovation depends not only on technology, but also on our ability to build trust, embrace discomfort, and transform challenges into enduring impact. This episode is a powerful reflection on purpose-driven leadership and the human side of scientific progress. "We transform loss into enduring impact." MEET OUR GUEST Greg Tietjen Co-Founder and CEO at Revalia Bio. Greg Tietjen is the CEO and co-founder of Revalia Bio, where he leads the team pioneering Revalia’s Human Data Trials™ — a new class of preclinical and clinical companion studies that generate human-relevant data before a drug ever reaches a patient. These trials are powered by Revalia’s Human Data Stack™: an integrated platform that connects perfused non-transplantable human organs, de-identified patient records, biopsy data, organ-on-chip systems, and advanced AI/ML analytics into a unified model of human biology. Greg and the team’s founding insight was that non-transplantable human organs — often discarded due to conditions like cancer or fibrosis — could serve as the Rosetta Stone of the Human Data Stack™. These organs provide unmatched physiological relevance and enable the integration of otherwise siloed human data sources. This approach gives new purpose to donated organs that would otherwise go unused, transforming the tragic loss of one person into a platform capable of enabling others to develop breakthrough therapies that may save countless lives. It’s a system built on honoring donor gifts while bringing together care teams, biotech innovators, and regulators as One Team, moving at lightning speed to transform the future of medicine together. Greg’s path to biotech was anything but conventional. After earning a degree in Literature and training to be a musician, a severe elbow injury forced him to change course. He went on to complete a PhD in Biophysics at the University of Chicago and postdoctoral training in Biomedical Engineering at Yale. As a faculty member at the Yale School of Medicine, his lab became internationally recognized for advancing the frontiers of human organ research. In 2023, Greg left his tenure-track role at Yale to build Revalia full-time. Today, he’s focused on laying the foundation for a new era of biomedical innovation — one that is ethically grounded, operationally scalable, and powered by real human data.

    Human Data Revolution – Greg Tietjen
  5. 21 may

    Leading Through Service – Justin McKay

    In this episode of Spread Love in Organizations, Naji Gehchan sits down with Justin McKay, co-founder of Radiological Care Services (RCS), to explore how a personal healthcare experience sparked a mission-driven company focused on patient and staff safety. After contracting an infection from contaminated X-ray garments while working in hospitals, Justin realized a major gap existed in infection prevention practices. What began as frustration turned into purpose, leading him to build RCS from the ground up despite years of uncertainty, financial struggle, and skepticism from the industry. Justin shares his deeply personal journey growing up in rural Indiana, raised by a single mother who instilled in him the values of service, humility, and generosity. Those early lessons shaped not only his entrepreneurial resilience but also the culture he intentionally built at RCS. Today, the company has grown into a national organization rooted in servant leadership, where employees are encouraged to serve their communities, care for one another, and bring humanity back into the workplace. The conversation also dives into the broader challenges facing healthcare today, from patient safety and infection prevention to leadership and organizational culture. Justin speaks candidly about why he believes healthcare still has work to do, while remaining hopeful about innovation and positive change. Above all, this episode is a powerful reminder that businesses thrive when people feel valued, seen, and loved - and that spreading love in organizations is not optional, but essential to meaningful leadership. "People over profits. Every single time." MEET OUR GUEST Justin McKay, Co-Founder, RadCare Services. Justin McKay is the Co-Founder of Radiological Care Services (RCS), a leading provider of X-ray garment cleaning and sanitization solutions. With over 15 years of experience in the healthcare industry, Justin is passionate about patient and staff safety. Driven by a personal experience with a hospital-acquired infection linked to contaminated X-ray garments in 2012, Justin co-founded RCS in 2013. Since then, he has spearheaded the company’s growth, transforming it from a cleaning service to a comprehensive solutions platform. Prior to RCS, Justin held leadership positions in national sales at Ferris Mfg. Corp., a manufacturer of medical textiles. Justin is a recognized expert in X-ray garment care and infection prevention. He leverages his expertise to collaborate with healthcare departments, developing customized programs that deliver value, consistency, and measurable outcomes.

    Leading Through Service – Justin McKay
  6. 7 may

    Research With Purpose – Elisabetta Vitali

    In this episode, Naji welcomes Elisabetta Vitali, Executive Director of the Giovanni Armenise Harvard Foundation, to explore her unique journey from high-level finance to leading a mission-driven organization at the intersection of science and philanthropy. After a successful career in investment banking and infrastructure funds, Elisabetta made a deeply personal and values-driven transition into the nonprofit world, motivated by her own health experiences, her family background in science, and a desire to contribute meaningfully to both scientific progress and her home country of Italy. Elisabetta shares the powerful story behind the Foundation, born from a personal tragedy that highlighted the urgent need for deeper investment in basic science. Today, the organization supports early-stage, high-risk research and fosters collaboration between Italy and the United States, with a strong focus on developing scientific talent. Through initiatives like career development awards, the Foundation not only funds research but invests in people, helping scientists build labs, grow careers, and create long-term impact across borders. Their work demonstrates how sustained commitment to fundamental science can generate ripple effects in innovation, education, and global collaboration. Throughout the conversation, Elisabetta reflects on leadership, legacy, and the importance of humanity in science. She emphasizes motivation, respect, and long-term vision as key drivers of impactful leadership, especially in fields where results may take years to materialize. Her perspective highlights a powerful truth: advancing science is not just about discoveries, but about nurturing communities, empowering individuals, and building systems that allow knowledge - and people - to thrive. "Without investing in basic science, we’re basically trying to build the skyscraper starting from the roof." MEET OUR GUEST Elisabetta Vitali, Executive Director of the Giovanni Armenise Harvard Foundation. Elisabetta Vitali is the Executive Director of the Giovanni Armenise Harvard Foundation, a role she has held since February 2025, after more than a decade of leading the Foundation’s Italian Programs. With over 25 years of international experience across philanthropy, finance, and strategic management, she brings a distinctive combination of analytical depth, leadership, and cross-sector vision to advancing the Foundation’s mission of supporting world-class scientific research and fostering collaboration between Italy and the United States. Before joining the Foundation in 2014, Elisabetta built a successful career in investment banking and infrastructure finance. She served as Vice President at Lazard & Co., where she advised leading European corporations on mergers, acquisitions, and complex cross-border transactions totaling more than €3.5 billion. She later joined AEDES SpA, supporting the firm’s international expansion and fund management strategy, and became one of the investment partners at F2i SGR, Italy’s largest infrastructure fund, where she oversaw major transactions in energy, transportation, and utilities, contributing to a portfolio exceeding €2 billion. Drawing on her financial and strategic background, Elisabetta transitioned to the nonprofit sector, where she has since applied the same rigor and long-term vision to advancing scientific excellence and collaboration across the Boston and Italy. At the Armenise Harvard Foundation, she has launched several key initiatives—including the Armenise Harvard Airalzh and INF-ACT Mid-Career Awards—and strengthened partnerships between Italian institutions, Harvard Medical School, and global research organizations. A graduate of Bocconi University with full honors in Economics and Social Disciplines, Elisabetta is known for her ability to connect people and ideas across sectors and borders, and commitment to translating strategy into lasting impact for science and society.

    Research With Purpose – Elisabetta Vitali
  7. 28 abr

    AI For Humanity – Mona Flores

    In this episode of Spread Love in Organizations, Naji Gehchan sits down with Mona Flores, a physician, former Global Head of Medical AI at NVIDIA, and a leader at the intersection of healthcare, technology, and impact. Mona shares her unconventional journey from investment banking to cardiac surgery and ultimately to pioneering work in artificial intelligence. She reflects on the power of reinvention, the importance of following purpose over plan, and how her experiences shaped a vision of scaling healthcare impact from one patient to millions through AI-driven innovation. The conversation explores both the present and future of AI in healthcare - from improving workflows today to enabling entirely new, AI-native approaches to drug discovery, diagnostics, and disease prevention. Mona also highlights her humanitarian work through the “Your Turn” campaign, mobilizing global tech talent to support Lebanon. Grounded in a deep sense of purpose, she challenges healthcare leaders to embrace AI without fear, focus on real-world impact, and use their “one life” to create meaningful change at scale. "Don’t be afraid of AI, be afraid of not using it to make the world better." MEET OUR GUEST Mona Flores, physician and healthcare innovator with a passion for advancing medicine and science through artificial intelligence, former Global Head of Medical AI at NVIDIA. Mona Flores is a physician and healthcare innovator with a passion for advancing medicine and science through artificial intelligence. As the former Global Head of Medical AI at NVIDIA, she helped build and lead a global ecosystem bringing AI technologies into healthcare. She completed her medical training at OHSU, UC San Diego, Stanford, and Columbia, and also holds an MBA and a Master's in Biology. With experience spanning cardiothoracic surgery, digital health, and investment banking, Mona brings a multidisciplinary perspective to solving healthcare's most complex challenges. She continues to work at the forefront of AI, science, and medicine, focused on scalable innovation that improves patient care and drives meaningful impact. To learn more, go to the Campaign site yourturnlebanon.com and you can also follow here. More about BIOLINK.org here, and for more episodes with BioLinkers click here.

    AI For Humanity – Mona Flores
  8. 23 abr

    Biotech Leader Ecosystem- Catharine Smith & Jason Cordeiro

    In this episode of Spread Love in Organizations, Naji Gehchan welcomes Catharine Smith and Jason Cordeiro for a conversation on leadership, ecosystem building, and the future of biotech. Catharine Smith, an experienced healthcare and nonprofit leader, shares her journey from clinical and health system roles to leading the Tremier Institute, where she focuses on developing the next generation of biotech leaders. Jason Cordeiro, Chief Operating and Innovation Officer at MassBio, reflects on his path from scientific research to ecosystem leadership, emphasizing his passion for connecting innovators and enabling the development of new therapies for patients. The discussion highlights the strategic partnership between the Tremier Institute and MassBio, including the creation of the Founder Link initiative. Both guests explain how this collaboration emerged from shared goals and parallel strategic planning processes, ultimately aiming to strengthen the early-stage biotech ecosystem in Boston and beyond. By combining MassBio’s extensive industry network with the Tremier Institute’s leadership development expertise, the partnership provides founders and executives with a structured space for connection, learning, and peer support. The conversation also explores the evolving definition of leadership in healthcare and biotech. Catharine and Jason emphasize that leadership is not only a skill that can be learned but one rooted in empathy, human-centered thinking, and purpose. They stress the importance of community, resilience, and aligning innovation with patient impact. The episode closes with reflections on “spreading love in organizations,” underscoring the belief that kindness, authenticity, and strong relationships are essential to building meaningful, high-impact healthcare organizations. "In biotech, progress happens when leadership, community, and science come together to improve humanity." MEET OUR GUESTS Catharine Smith CEO of the Termeer Institute, & Jason Cordeiro Chief Operating & Innovation Officer, MassBio. Catharine Smith is a mission-driven executive leader with more than 15 years of experience scaling high-impact organizations at the intersection of healthcare, innovation, and equity. As the inaugural CEO of the Termeer Institute, she has built an international leadership organization from the ground up, launching global partnerships and scaling programs that expand access and opportunity for emerging leaders across the biotechnology ecosystem. Prior to the Termeer Institute, Catharine served as the CEO of the Clinton Health Matters Initiative at the Clinton Foundation where she led a team focused on stigma reduction and overdose prevention related to the opioid epidemic.  Known for her inclusive leadership and ability to bridge sectors, Catharine is a trusted voice on leadership, health equity, and innovation, regularly teaching and speaking at international forums. Catharine’s leadership is grounded in a deep commitment to advancing women and underrepresented leaders, supporting emerging talent, and building ecosystems where diverse voices shape the future of leadership.  Catharine is a Fulbright Scholar and holds a master’s degree in business administration from the Massachusetts Institute.  Jason Cordeiro is the Chief Operating & Innovation Officer. He joined MassBio in September of 2018 as the Vice President of Consortium Operations. In his current role, Jason is responsible for helping drive MassBio’s strategic vision and ensuring the organization is always positioned to support the industry. He is responsible for leading the membership organization and focuses on industry partnering and early-stage company support through our Partnering programs and Edge services. In his tenure at MassBio, Jason has overseen the launch of several new programs, including MassBioDrive, Align Summit, and the MassBioHub. Jason received a B.S. in Biology from Emmanuel College. He had worked at BIDMC researching the effects of NSAIDS on ovarian, prostate, and breast cancers and had spent nine years with Thermo Fisher Scientific in various commercial roles. Jason combines his professional talents and love for the outdoors as he sits on the board of Elevate Youth, a local organization. He currently resides on the South Shore with his wife and two children. More Episode in partnership with the Termeer Institute can be found here. Give them a listen!

    Biotech Leader Ecosystem- Catharine Smith & Jason Cordeiro

Acerca de

The Healthcare Leadership Podcast. Because we believe we can change the world by leading from a place of love. One story at a time. Hear global leaders' personal stories and inspiring journeys spreading love in their organizations bringing genuine care for people to thrive resulting in a positive impact for the company’s stakeholders and healthcare globally. https://spreadloveio.com/ https://www.linkedin.com/company/spreadloveio/ https://linktr.ee/spreadloveio